Dr Roland Kozlowski

Roland Kozlowski, has 13 years biotech experience. He is the principal founder and CEO of Lectus Therapeutics Limited. He has led the company from its initiation in 2003 and in 2006 closed an £8.2m series A financing round. Until December 2002 he was CEO and principal founder of Sense Proteomic Limited. At Sense he raised a total of £5.75m from private equity sources and in 2002 sold the business to Procognia Limited as part of a $4m financing round. Before that, he worked with Oxford Molecular where he negotiated their corner stone drug discovery deal with Yamanouchi Pharmaceutical Corp.: a program he subsequently directed.

Roland, is on the Main Board of the Bio Industry Association. He holds a First Class Honours Degree in Pharmacology (University of Bath) and a PhD in Pharmacology (University of Cambridge). He has held positions at both Oxford and Bristol Universities.